Remove topic addiction
article thumbnail

Incannex engages QPS for CannQuit and ReneCann

Pharmaceutical Technology

The company will provide regulatory advice to Incannex, and manage clinical trials to develop CannQuit and ReneCann products to treat addiction and immune-disordered skin diseases. CannQuit-Opioid, named CheWell, combines CBD and an opioid antagonist/agonist in a water-soluble chewable tablet to treat opioid addiction.

article thumbnail

Beckley Psytech raises $80m for psychedelic meds development

pharmaphorum

The Oxford-based company had originally hoped to raise $50 million from the series B, and the scale of the financing is further evidence that repurposing psychedelic compounds as potential therapies for neuro-psychiatric disorders is a hot topic in biopharma. Beckley – formerly known as Beckley Canopy Therapeutics – raised £7.4

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Expanding ketamine’s horizons to treat rare neurological disorders

Pharmaceutical Technology

Earlier this month, New Jersey-based Silo Pharma announced the start of an IND-enabling study of a topical ketamine formulation for fibromyalgia, a chronic condition that causes pain and fatigue. This has led to questions about the drug’s real-world use, as these addictive properties need to be considered, says Sanacora.

Research 275
article thumbnail

Grünenthal takes non-opioid pain drug resiniferatoxin into phase 3

pharmaphorum

Grünenthal has moved its painkiller resiniferatoxin into phase 3 trials in patients with osteoarthritis, hoping to find an option that sidesteps the side effects and addictive potential of opioid drugs.

Drugs 52
article thumbnail

CVD Biomarker Levels Up for Dual Use of E-Cigarettes, Cigarettes

The Pharma Data

from the American Heart Association Tobacco Regulation and Addiction Center in Dallas, and colleagues examined the correlation of cigarette and e-cigarette use behaviors with biomarkers of inflammation and oxidative stress among adults aged 18 years and older from the Population Assessment of Tobacco and Health Study. MONDAY, Jan.

Protein 52
article thumbnail

Purdue Pharma to Plead Guilty to Opioid-Related Crimes

The Pharma Data

The settlement is the federal government’s biggest win in seeking to hold a major drug company responsible for an addiction and overdose crisis tied to more than 470,000 deaths in the United States since 2000, the AP says. Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Doctors 52
article thumbnail

NABP and Opioid Death in the U.S.

Pharmacy Checkers

pharmacy retail giants – including Walgreens, CVS, Rite Aid, and Walmart – were “as complicit in perpetuating the crisis as the manufacturers and distributors of the addictive drugs.”. That’s a noble topic, but it’s also useful to deflect from breaking news about Big Pharmacy drug dealing! Afterall, it is the U.S.